Pierre Guerin Company Profile

21:51 EDT 24th March 2018 | BioPortfolio

BIOLAFITTE Aseptic Processes Expertise support the Health Industries focused on the Biotech, Pharmaceutical and Cosmetics markets.

Our areas of competence include :

- Fermenter / Bioreactor process design and manufacturing of complete systems.

- Project management

- Process engineering (P&ID, functional analysis)

- Mechanical design (vessels and piping - 3D isometric drawings)

- Electrical and control system design, programming

- Piping manufacturing and wiring

- Commissioning and after-sales services

- Qualification support (cGMP,GAMP,CFR21 part11)

These technical skills combined with our in house process vessel manufacturing, after-sales service, and distribution network allow us to provide a full range of products and services that meets the needs of our worldwide customer base.


179, Grand'Rue BP 12


Phone: + 33 (0)5 49 04 78 00

News Articles [47 Associated News Articles listed on BioPortfolio]

Pierre Fabre out-licenses F17727

Pierre Fabre Pharmaceuticals has entered into a worldwide licensing agreement for it selective potassium…

Boardriders, Inc. Announces Pierre Agnes Memorials

Dave Tanner, CEO of Boardriders, Inc. said: "Pierre loved the beauty of the ocean, and lived his life on the water as a surfer Read more...

Boardriders Inc. gibt Statement über CEO Pierre Agnes heraus

Am frühen Morgen des heutigen Tages tat unser CEO Pierre Agnes, was er oftmals tat: Er fuhr mit seinem Boot zum Fischen aus, um Read more...

Boardriders, Inc. distribui declaração sobre o CEO Pierre Agnes

Bem cedo na manhã de hoje, nosso CEO Pierre Agnesfez o que costuma fazer em muitas manhãs: foi pescar em seu querido barco, para Read more...

Institut Curie, Pierre Fabre Partner on immuno-oncology

Institut Curie and the IRPF (Institut de Recherche Pierre Fabre) will collaborate on new therapeutic strategies to advance cancer treatment for patients. The objective of this novel partnership is to ...

Boardriders, Inc. publica declaración sobre el director ejecutivo Pierre Agnes

Temprano por la mañana nuestro director ejecutivo, Pierre Agnes, hizo lo mismo que muchas mañanas y salió de pesca a bordo de su adorada Read more...

Local Chiropractor Dr. Jean-Pierre of Upper Cervical Institute of Florida Says He Will Work for Toys

Boca Raton, FL, October 31, 2017 --( A Boca Raton Chiropractor, Dr. Gregory Jean-Pierre is using is office as collection center for Toys For Tots. Dr. Jean-Pierre has announced that from now...

Boston Pharmaceuticals gets global rights to preclinical cardio compound from Pierre Fabre

Pierre Fabre Group licensed Boston Pharmaceuticals Inc. exclusive worldwide rights to develop, manufacture, and commercialize its selective potassium channel blocker F17727 for atrial fibrillation. ...

PubMed Articles [37 Associated PubMed Articles listed on BioPortfolio]

The Pierre Robin Mandible is Hypoplastic and Morphologically Abnormal.

For Pierre Robin sequence (PRS) patients, there is incomplete characterization of 3D differences and effects of mandibular distraction osteogenesis (MDO) on the mandible compared to normal controls.

An Algorithm for Airway Management in Patients With Pierre Robin Sequence.

Airway management in neonates with Pierre Robin sequence (PRS) can be challenging. The goal was to describe the algorithm developed by the authors over the past 8 years.

A comprehensive scoring system in correlation with perioperative airway management for neonatal Pierre Robin Sequence.

To evaluate a comprehensive scoring system which combines clinical manifestations of Pierre Robin Sequence (PRS) including severity of breathing difficulties, body weight and preoperative Cormack-Leha...

Postoperative Respiratory Complications After Cleft Palate Closure in Patients With Pierre Robin Sequence: Operative Considerations.

In cleft palate surgery, there is currently no consensus on the management of patients with Pierre Robin Sequence (PRS). The authors aimed to evaluate the treatment strategy of cleft palate in our cen...

Dose, duration and strain of bacillus Calmette-Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials.

Intravesical bacillus Calmette-Guerin (BCG) instillation is widely used as an adjuvant therapy after transurethral resection of bladder tumor (TURBT) in patients with intermediate- and high-risk nonmu...

Clinical Trials [40 Associated Clinical Trials listed on BioPortfolio]

Impact of Phonatory and Facial Morphology Disorders, on the Quality of Life of Adolescents With Pierre Robin Sequence

The study team has made the hypothesis that the intensity of the phonatory disorders (rhinolalia), and of the maxillo-mandibular growth anomalies (facial morphology), may have negative eff...

Early Treatment Outcomes in Pierre-Robin-Like Phenotype

In a longitudinal cohort study, we want to assess the effect of the pre-epiglottic baton plate, the main treatment approach currently used in Germany for Pierre-Robin-Like phenotype, on up...

Trial of Melaxin Cancer Vaccine Plus Bacillus Calmette-Guerin (BCG) to Treat Malignant Melanoma

The purpose of this study is to determine if treatment with the autologous cellular vaccine, Melaxin, in combination with Bacillus Calmette-Guerin (BCG) injections is effective in Stage I...

Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients

The purpose of this study is to compare the bladder cancer treatments, Mitomycin C (MMC) and Bacillus Calmette Guerin (BCG), to find out which is better. In this study, the patient will ge...

Revaccination of Young Children With Bacille Calmette Guerin (BCG) Vaccine

BCG has marked immune stimulatory effects in both animal and human studies and observational studies suggest that BCG is associated with a non-specific reduction in mortality in areas with...

Companies [29 Associated Companies listed on BioPortfolio]


Supporting Food and Health industriesA specialist in stainless steel products and a designer and manufacturer of process vessels integrating sophisticated and innovative features in agitation, mixing,...


1949Pierre Guérin creates his company in Mauzé sur le Mignon in Southwestern France, developed from a family business in dairy farm equipment and maintenance. Supporting the Food and Health industri...

Pierre Fabre SA

Pierre Fabre group, France's second biggest independent pharmaceutical laboratory, achieved a turnover of 1.75 billion euros in 2008. Approximatively 10,000 people including 1,400 in the research ...

Groupe Pierre Fabre

The Pierre Fabre Group, the second largest independent French pharmaceutical company and leader in the field of in-pharmacy dermo-cosmetics, employs about 10,000 people worldwide, including 1,400 ...

Pierre Guerin

BIOLAFITTE Aseptic Processes Expertise support the Health Industries focused on the Biotech, Pharmaceutical and Cosmetics markets.Our areas of competence include :- Fermenter / Bioreactor process desi...

More Information about "Pierre Guerin" on BioPortfolio

We have published hundreds of Pierre Guerin news stories on BioPortfolio along with dozens of Pierre Guerin Clinical Trials and PubMed Articles about Pierre Guerin for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Pierre Guerin Companies in our database. You can also find out about relevant Pierre Guerin Drugs and Medications on this site too.

Quick Search


Relevant Topics

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Corporate Database Quicklinks

Searches Linking to this Company Record